| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Infanrix hexa | Pulver und Suspension zur Herstellung einer Injektionssuspension | Injection suspension () + Injection suspension (Toxoidum Diphtheriae 30U.I. / 0.5ml, Toxoidum Tetani 40U.I. / 0.5ml, Toxoidum Pertussis 25µg / 0.5ml, Haemagglutininum Filamentosum (B. Pertussis) 25µg / 0.5ml, Pertactinum (B. Pertussis) 8µg / 0.5ml, Virus Poliomyelitis Typus 1 Inactivatus (Mahoney) 40U.I. / 0.5ml, Virus Poliomyelitis Typus 2 Inactivatus (Mef1) 8U.I. / 0.5ml, Virus Poliomyelitis Typus 3 Inactivatus (Saukett) 32U.I. / 0.5ml, Hepatitidis b viri Antigenum Adnr 10µg / 0.5ml) | J07CA09 | | | 02 | Infanrix hexa | | (Toxoidum Diphtheriae 0 UI, Toxoidum Tetani 0 UI, Toxoidum Pertussis 25 mcg, Haemagglutinium Filamentosum (B. Pertussis) 25 mcg, Pertactinum (B. Pertussis) 8 mcg, Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 UI, Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 UI, Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 UI, Vaccinum Hepatitidis b (Adnr) Hbsag 10 mcg, Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg) | | | | 03 | Infanrix hexa | | (Toxoidum Diphtheriae 30 UI, Toxoidum Tetani 40 UI, Toxoidum Pertussis 25 mcg, Haemagglutinium Filamentosum (B. Pertussis) 25 mcg, Pertactinum (B. Pertussis) 8 mcg, Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) 40 UI, Virus Poliomyelitis Typus 2 Inactivatum (Mef1) 8 UI, Virus Poliomyelitis Typus 3 Inactivatum (Saukett) 32 UI, Vaccinum Hepatitidis b (Adnr) Hbsag 10 mcg, Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg) | | |
|
